ADORKEM TECHNOLOGY SPA has a total of 52 patent applications. Its first patent ever was published in 2003. It filed its patents most often in EPO (European Patent Office), WIPO (World Intellectual Property Organization) and China. Its main competitors in its focus markets organic fine chemistry, biotechnology and pharmaceuticals are HANGZHOU KEXING BIOCHEM CO LTD, SUZHOU TONGLI BIOMEDICAL CO LTD and GLAXO WELLCOME SA.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 10 | |
#2 | WIPO (World Intellectual Property Organization) | 8 | |
#3 | China | 7 | |
#4 | Italy | 6 | |
#5 | Brazil | 5 | |
#6 | Canada | 4 | |
#7 | Mexico | 4 | |
#8 | United States | 3 | |
#9 | Hong Kong | 2 | |
#10 | Croatia | 1 | |
#11 | Poland | 1 | |
#12 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Organic fine chemistry | |
#2 | Biotechnology | |
#3 | Pharmaceuticals | |
#4 | Foods and drinks | |
#5 | Environmental technology |
# | Name | Total Patents |
---|---|---|
#1 | Cotticelli Giovanni | 42 |
#2 | Salvetti Raul | 26 |
#3 | Di Lernia Gianluca | 8 |
#4 | Milanesi Silvia | 6 |
#5 | Bertoni Chiara | 6 |
#6 | Rocchietti Silvia | 6 |
#7 | Terreni Marco | 6 |
#8 | Pregnolato Massimo | 6 |
#9 | Lernia Gianluca Di | 5 |
#10 | Dall Asta Leone | 3 |
Publication | Filing date | Title |
---|---|---|
WO2008093378A1 | Process of selective enzymatic enrichment of a mixture containing omega-3 | |
WO2007144168A1 | Enzymatic process for preparation of 5'-monophosphate-nucleotides | |
EP1777221A1 | Process for the preparation of 5-cyanophthalide starting from 5-carboxyphthalide | |
CN101048396A | Process for the preparation of citalopram and escitalopram | |
EP1736550A1 | Chemoenzymatic process for the synthesis of escitalopram | |
EP1733042A1 | Chemo-enzymatic process for preparing escitalopram | |
CN1867575A | Process for the preparation of fludarabine phosphate | |
MXPA05008411A | Process for the preparation of a cyano-isobenzofuran. | |
EP1506963A1 | Method for the preparation of citalopram | |
EP1439220A1 | Immobilized biocatalysts usable for the manufacture of natural nucleosides and modified analogues through enzymatic transglycosylation reactions |